CASI Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Rockville MD United States (1991)

Organization Overview

First Clinical Trial
2001
NCT00592579
First Marketed Drug
1991
spironolactone (aldactone)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CASI Pharmaceuticals, Inc. | CASI PHARMS INC